About us
Careers
Contact
AI-Immunology™
Pioneer™ & ObsERV™
Eden™
Raven™
Pipeline
Product candidates
R&D
AI Immuno-Informatics
Laboratories
Animal Facility
Translational Medicine
Vaccine Manufacturing
Clinical Development
Partnerships
Partner with us
Our partnerships
Media
Press releases
Company presentation
Publications
Other Presentations
Investors
Analyst COverage
Evaxion shares
Reports & Filings
Corporate Governance
FAQ
Media
SEARCH
Menu
About us
AI-Immunology™
Pipeline
R&D
Partnerships
Media
Investors
About Us
Careers
Contact
Back
AI-Immunology™
Pioneer™ & ObsERV™
Eden™
Raven™
Back
Pipeline
Product candidates
Back
R&D
AI Immuno-Informatics
Laboratories
Animal Facility
Translational Medicine
Vaccine Manufacturing
Clinical Development
Back
Partnerships
Partner with us
Our partnerships
Back
Media
Press releases
Company presentation
Publications
Other Presentations
Back
Investors
Analyst COverage
Evaxion shares
Reports & Filings
Corporate Governance
FAQ
Media
Back
SEARCH
Get to know CEO Per Norlén
Redeye interviewed Evaxion’s newly appointed CEO, Per Norlén, about his background, reasons for joining the company, and hopes for the future.
By Redeye
Watch the interview